β-D-Allofuranuronic acid, 1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-5-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-, (S)- (9CI),162633-78-5-Amadis Chemical

Home > Product Catalog > Life science > Nucleosides > β-D-Allofuranuronic acid, 1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-5-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-, (S)- (9CI)

[CAS No.162633-78-5] A1254441 β-D-Allofuranuronic acid, 1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-5-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-, (S)- (9CI) 97%

Search after editing

Catalog No.: A1254441

Cas No.: 162633-78-5

Molecular Formula: C₂₆H₃₁N₅O₁₁

Molecular Weight: 589.55

MDL NO:

EINECS:

Order & Inquiry & Tech Support

Tel: 0086-571-89925085
Order & Inquiry: sales@amadischem.com
Tech Support: tech@amadischem.com

Request Quote

*All chemicals from Amadis Chemical are for laboratory or manufacturing use only.

Quality Control of [162633-78-5]

NMR

CNMR

HPLC

LC-MS

Related Doc. of[162633-78-5]

SDS

Specification

MOL

SDF

Product Details [162633-78-5]

Synonyms: β-D-Allofuranuronic acid, 1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-5-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-, (S)- (9CI)

Appearance:

Storage: Store in 2-8°C for long term (months)

Boiling point:

Melting point:

Flash point:

Pubchem ID:

Smiles: O[C@H]1[C@@H](O[C@]([C@H](NC([C@H](CC=2C=3C(NC2)=CC=C(O)C3)NC(OC(C)(C)C)=O)=O)C(O)=O)([C@H]1O)[H])N4C(=O)NC(=O)C=C4

InchiKey: RERJXYVXONRDBP-ODDPDQQYSA-N

Inchi: InChI=1S/C26H31N5O11/c1-26(2,3)42-25(40)28-15(8-11-10-27-14-5-4-12(32)9-13(11)14)21(36)30-17(23(37)38)20-18(34)19(35)22(41-20)31-7-6-16(33)29-24(31)39/h4-7,9-10,15,17-20,22,27,32,34-35H,8H2,1-3H3,(H,28,40)(H,30,36)(H,37,38)(H,29,33,39)/t15-,17-,18-,19+,20+,22+/m0/s1

Safety [162633-78-5]

GHS Pictogram:

Signal Word: Warning

Class:

Precautionary Statements: P261;P280;P305+P351+P338

UN No.:

Hazard Statements: H302;H315;H319;H332;H335

Packing Group:

Literatures [162633-78-5]

Sorry, the literature is not available.

Similar of [162633-78-5]

A1254193 100995-67-3

β-D-Allofuranuronic acid, 5-[[2-amino-3-(1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, (R)- (9CI)

Reason:Nucleosides

A1254211 86632-67-9

β-D-Allofuranuronic acid, 5-[[2-amino-3-(1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, (S)- (9CI)

Reason:Nucleosides

A1254236 151388-39-5

β-D-Allofuranuronic acid, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, (S)- (9CI)

Reason:Nucleosides

A1254525 162634-17-5

β-D-Allofuranuronamide, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-(phenylmethyl)-, (S)- (9CI)

Reason:Nucleosides

A1254530 162634-11-9

β-D-Allofuranuronamide, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-N-decyl-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-, (S)- (9CI)

Reason:Nucleosides

A1254533 162634-08-4

β-D-Allofuranuronamide, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-tetradecyl-, (S)- (9CI)

Reason:Nucleosides

A1254536 162634-05-1

β-D-Allofuranuronamide, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-octadecyl-, (S)- (9CI)

Reason:Nucleosides

A1254537 162634-04-0

β-D-Allofuranuronamide, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-dodecyl-, (S)- (9CI)

Reason:Nucleosides

A1254538 162634-03-9

β-D-Allofuranuronamide, 5-[[2-amino-3-(5-hydroxy-1H-indol-3-yl)-1-oxopropyl]amino]-1,5-dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-octyl-, (S)- (9CI)

Reason:Nucleosides

Description [162633-78-5]

Sorry, the product description is not available.

Browsing history